How Do Targeted Therapies and Immunotherapies Affect Dosage?
Targeted therapies and immunotherapies often have different dosing considerations compared to traditional chemotherapy. For example, targeted therapies like tyrosine kinase inhibitors (TKIs) may be dosed based on specific biomarkers or genetic mutations. Immunotherapies such as checkpoint inhibitors may have fixed dosing schedules or weight-based dosing.
